We further validated the Akt signaling pathway’s involvement in p32-mediated tumorigenesis using AKT inhibitor LY294002 in melanoma cells and found that p32-mediated in vitro tumorigenic properties of both murine B16F10 and human A375 melanoma cells are Akt-dependent. This evidence concerns the gene AKT1 and melanoma.